Nustendi®
(bempedoic acid) Daiichi Sankyo
Composition:
• Available as film-coated tablet containing 180 mg of bempedoic acid and 10 mg of ezetimibe
Indication:
• As an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C
